Back
Vivos Therapeutics, Inc. 10K Form
Sell
37
VVOS
Vivos Therapeutics, Inc.
Last Price:
$2.07
Seasonality Move:
8.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VVOS News And Ratings
See the #1 stock for the next 7 days that we like better than VVOS
VVOS Financial Statistics
Sales & Book Value
| Annual Sales: | $15M |
|---|---|
| Cash Flow: | $-4.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.31 |
| Price / Book: | 7.63 |
Profitability
| EPS (TTM): | -1.97370 |
|---|---|
| Net Income (TTM): | $-17.1M |
| Gross Margin: | $8.4M |
| Return on Equity: | -315.1% |
| Return on Assets: | -91.38% |
Vivos Therapeutics, Inc. Earnings Forecast
Key Vivos Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for VVOS is 56.14%.
-
The Selling, General & Administrative Expenses for VVOS have been equal to 130.46% of Gross Profit Margin.
-
The Research & Development expenses have been 0.67% of Revenue.
-
The Net Earning history of VVOS is -74.09% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 3 years.
Vivos Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | VVOS |
| Website: | vivos.com |
Debt
| Debt-to-Equity Ratio: | 4.94 |
|---|---|
| Current Ratio: | 0.78 |
| Quick Ratio: | 0.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VVOS Technical Analysis vs Fundamental Analysis
Sell
37
Vivos Therapeutics, Inc. (VVOS)
is a Sell
Is Vivos Therapeutics, Inc. a Buy or a Sell?
-
Vivos Therapeutics, Inc. stock is rated a SellThe current Vivos Therapeutics, Inc. [VVOS] share price is $2.15. The Score for VVOS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.